索里亚美醇治疗成人注意力缺陷/多动障碍:双盲安慰剂控制试点研究
Craig B H Surman1,2, Daniel M Walsh1, Nora Horick1
1Clinical and Research Program in Adult ADHD, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
The Journal of clinical psychiatry
|October 11, 2023
概括
索里亚美醇作为治疗成人注意力缺陷/多动障碍 (ADHD) 的新疗法具有前景. 该研究发现它有效改善ADHD症状和执行功能,具有良好的耐受性.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 注意缺陷/多动障碍 (ADHD) 影响成年人,有些人对现有治疗没有反应.
- 对于成人多动症管理,需要新的治疗策略.
研究的目的:
- 评估solriamfetol在成人ADHD治疗中的疗效和耐受性.
- 为了确定solriamfetol是否与安慰剂相比提供了有利的治疗概况.
主要方法:
- 一项为期6周的随机,双盲,安慰剂对照试验,涉及60名ADHD成年人.
- 优化solriamfetol (75毫克或150毫克) 的剂量,包括成人多动症调查者症状评级表 (AISRS) 的评估.
主要成果:
- 索里亚姆醇在ADHD症状 (AISRS分数) 和执行功能 (BRIEF-A) 中显著改善.
- 治疗一般耐受良好,对生命体征没有显著影响.
- 与安慰剂相比,食欲下降和失眠等不良事件更频繁,但在统计学上没有显著意义.
结论:
- 索里亚美醇可能代表成人多动症的新且有效的治疗选择.
- 需要在更大的临床试验中进行进一步的研究来证实这些发现.
相关概念视频
Attention-Deficit/Hyperactivity Disorder
76
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
76
Sedatives and Hypnotics Drugs: Miscellaneous Agents
184
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
184
Antidepressant Drugs: MAOIs and Other Agents
256
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
256
Adrenergic Agonists: Therapeutic Uses
825
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
825
Adrenergic Agonists: Mixed-Action Agents
756
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
756
Management of Insomnia
262
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
262


